PROKIDNEY CORP. (PROK) Form 8-K — Oct 29, 2026
ProKidney Corp. entered into an Open Market Sale Agreement with Jefferies LLC on October 29, 2026, establishing an at-the-market (ATM) equity offering program. Under the agreement, ProKidney may sell Class A common stock from time to time for up to $200,000,000 in aggregate offering price, subject to effectiveness of a new Form S-3 shelf registration filed the same day. Jefferies will receive compensation of up to 3.0% of gross proceeds.
Key figures
- Gross Proceeds
- $200,000,000 maximum aggregate offering price
- Offering Price
- at-the-market (price determined at time of sale)
- Sales agent commission
- up to 3.0% of gross proceeds
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.